Network Pharmacology Reveals the Mechanism of Activity of Tongqiao Huoxue Decoction Extract Against Middle Cerebral Artery Occlusion-Induced Cerebral Ischemia-Reperfusion Injury

被引:15
|
作者
Wu, Si-peng [1 ,2 ]
Wang, Ning [1 ,3 ,4 ]
Zhao, Li [1 ,3 ,4 ]
机构
[1] Anhui Univ Chinese Med, Key Lab Chinese Med Formula Anhui Prov, Hefei, Peoples R China
[2] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China
[3] Anhui Acad Chinese Med, Inst Pharmacodynam & Safety Evaluat Chinese Med, Hefei, Peoples R China
[4] Minist Educ, Key Lab Xinan Med, Hefei, Peoples R China
基金
中国国家自然科学基金;
关键词
Tongqiao Huoxue Decoction; cerebral ischemia reperfusion injury; angiogenesis; vascular endothelial growth factor; network pharmacology; ANGIOGENESIS; DISRUPTION;
D O I
10.3389/fphar.2020.572624
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several clinical therapies such as tissue repair by replacing injured tissues with functional ones have been reported; however, there is great potential for exploring traditional herbal-induced regeneration with good safety. Tongqiao Huoxue Decoction (TQHXD), a well-known classical traditional Chinese medicinal formula, has been widely used for clinical treatment of stroke. However, biological activity and mechanisms of action of its constituents toward conferring protection against cerebral ischemia-reperfusion (I/R) injury remain unclear. In this present study, we evaluated TQHXD quality using HPLC; then, it was screened for its potential active ingredients using a series of indices, such as their drug-likeness and oral bioavailability. Subsequently, we analyzed the potential mechanisms of TQHXD anti-I/R using gene ontology functional enrichment analyses. The network pharmacological approach enabled us to screen 265 common targets associated with I/R, indicating that TQHXD had remarkable protective effects on infarction volume, neurological function scores, and blood-brain barrier (BBB) injury. In addition, TQHXD significantly promoted the recovery of regional cerebral blood flow (rCBF) 7 days after reperfusion compared to rats in the vehicle group. Immunofluorescence results revealed a significantly higher CD34 expression in TQHXD-treated rats 7 days after reperfusion. TQHXD is not merely effective but eventually develops a secretory profile composed of VEGF and cerebral blood flow, a typical signature termed the angiogenesis-associated phenotype. Mechanistically, our data revealed that TQHXD (6 g/kg) treatment resulted in a marked increase in expression of p-focal adhesion kinase (FAK) and p-Paxillin proteins. However, Ki8751-mediated inhibition of VEGFR2 activity repealed its angiogenesis and protective effects and decreased both p-FAK and p-Paxillin protein levels. Taken together, these findings affirmed the potential of TQHXD as a drug for the management of stroke, which might be exerted by increasing the angiogenesis via the VEGF pathway. Therefore, these results provide proof-of-concept evidence that angiogenesis is a major contributor to TQHXD-treated I/R and that TQHXD is a promising traditional ethnic medicine for the management of this condition.
引用
收藏
页数:13
相关论文
共 50 条
  • [11] Effect of Celastrol on LncRNAs and mRNAs Profiles of Cerebral Ischemia-Reperfusion Injury in Transient Middle Cerebral Artery Occlusion Mice Model
    Liu, Jiandong
    Guo, Xiangna
    Yang, Lu
    Tao, Tao
    Cao, Jun
    Hong, Zexuan
    Zeng, Fanning
    Lu, Yitian
    Lin, Chunshui
    Qin, Zaisheng
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [12] Herbal extract prevented brain injury induced by cerebral ischemia-reperfusion
    Gulyaev, Sergey M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 44 - 44
  • [13] Effect of dexmedetomidine on ncRNA and mRNA profiles of cerebral ischemia-reperfusion injury in transient middle cerebral artery occlusion rats model
    Zhang, Zhen Zhen
    Nasir, Abdul
    Li, Dong
    Khan, Suliman
    Bai, Qian
    Yuan, Feng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [14] Protection of Vitexin against Cerebral Ischemia-reperfusion Injury in Mice and the Mechanism
    Chen, Dandan
    Liu, Chunyu
    Dong, Ying
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (09): : 1798 - 1804
  • [15] The neuroprotective effects of isosteviol against focal cerebral ischemia injury induced by middle cerebral artery occlusion in rats
    Xu, Deyi
    Du, Wenfeng
    Zhao, Lei
    Davey, Andrew K.
    Wang, Jiping
    PLANTA MEDICA, 2008, 74 (08) : 816 - 821
  • [16] Neuroprotective Activity of Farnesol against Bilateral Common Carotid Artery Occlusion Induced Cerebral Ischemia/Reperfusion Injury in Mice
    Lisha, Joshi
    Saravanana, J.
    Santilna, K. S.
    Praveen, T. K.
    Rajkumar, P.
    Wadhwani, Ashish D.
    Kiran Pindiprolu, Sai
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (03): : 572 - 578
  • [17] Postischemic administration of liposome-encapsulated luteolin prevents against ischemia-reperfusion injury in a rat middle cerebral artery occlusion model
    Zhao, Gang
    Zang, Shao-Yun
    Jiang, Zhi-Hua
    Chen, Yao-Yue
    Ji, Xun-He
    Lu, Bu-Feng
    Wu, Jia-Hu
    Qin, Guo-Wei
    Guo, Li-He
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2011, 22 (10): : 929 - 936
  • [18] Neuroprotective effects of ocimum kilimandscharicum leaf extract against ischemia-reperfusion induced cerebral injury in mice
    Singh, V.
    Krishan, P.
    Shri, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 997 - 998
  • [19] Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats
    Chauhan, Anjali
    Sharma, Uma
    Jagannathan, N. R.
    Reeta, K. H.
    Gupta, Yogendra Kumar
    BEHAVIOURAL BRAIN RESEARCH, 2011, 225 (02) : 603 - 609
  • [20] Analysis of the mechanism of Buyang Huanwu Decoction against cerebral ischemia-reperfusion by multi-omics
    Zhou, Huifen
    Lin, Bingying
    Yang, Jiehong
    Wei, Xiaoyu
    Fu, Wei
    Ding, Zhishan
    He, Yu
    Wan, Haitong
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 305